Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Cantargia

4.10 SEK

-2.96 %

1,287 following

CANTA

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cantargia

2019202020212022202320242025
Revenue316.7
growth-%
EBITDA-111.6-173.9-370.3-381.6-290.0-168.6157.4
EBIT-111.6-173.9-370.3-381.6-290.0-168.6154.1
Profit before taxes-110.8-173.1-366.5-371.8-280.0-161.7147.0
Net income-110.8-173.1-366.5-371.8-280.0-161.7147.0
EPS-1.27-1.44-3.04-2.90-1.65-0.880.59
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %0.0 %
Login required

This content is only available for logged in users

Create account

Profitability and return on capital

2019202020212022202320242025
EBITDA-%49.7 %
EBIT-%48.7 %
ROE-77.9 %-19.4 %-68.8 %-95.4 %-166.0 %-139.0 %55.3 %
ROI-66.7 %-18.7 %-61.1 %-78.3 %-125.2 %-94.8 %49.5 %
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.